- Home
- PACB vs BETR Comparison
PACB vs BETR Comparison
Compare PACB & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PACB | BETR |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance: Consumer Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.8M | 518.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | PACB | BETR |
|---|---|---|
| Price | $1.41 | $24.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $1.67 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 5.9M | 303.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,468,000.00 | N/A |
| Revenue This Year | $11.32 | $55.02 |
| Revenue Next Year | $12.14 | $65.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $1.09 | $12.57 |
| 52 Week High | $2.73 | $94.06 |
Technical Indicators
Market Signals| Indicator | PACB | BETR |
|---|---|---|
| Relative Strength Index (RSI) | 43.60 | 45.06 |
| Support Level | $1.29 | $24.24 |
| Resistance Level | $1.45 | $31.07 |
| Average True Range (ATR) | 0.10 | 2.19 |
| MACD | -0.03 | -0.20 |
| Stochastic Oscillator | 12.00 | 27.54 |
Price Performance
Historical ComparisonAbout PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
About BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.